Creating Compassionate, Respected Online Rare Disease Communities: 7 Tips For Success
source: pixabay.com

Creating Compassionate, Respected Online Rare Disease Communities: 7 Tips For Success

In a previous article, I talked about the importance of patient-led advocacy groups and how they can positively impact how a rare diagnosis is received and understood by patients.  Do…

Continue Reading Creating Compassionate, Respected Online Rare Disease Communities: 7 Tips For Success
Results from Phase 1 HATTR Amyloidosis Trial Presented at Recent Meeting
source: pixabay.com

Results from Phase 1 HATTR Amyloidosis Trial Presented at Recent Meeting

According to a story from globenewswire.com, the clinical company Prothena Corporation plc recently presented encouraging results from its phase 1 clinical trial. This trial was evaluating its investigational product candidate…

Continue Reading Results from Phase 1 HATTR Amyloidosis Trial Presented at Recent Meeting
A Young Woman With Fibronectin Glomerulopathy Was Treated Successfully With Prednisone
source: pixabay.com

A Young Woman With Fibronectin Glomerulopathy Was Treated Successfully With Prednisone

It is now commonplace for patients to find that a drug such as prednisone, usually prescribed for relief of allergic and rheumatic symptoms, is also prescribed to treat leukemia. According…

Continue Reading A Young Woman With Fibronectin Glomerulopathy Was Treated Successfully With Prednisone
Patients with Unresectable Colorectal Liver Metastases and KRAS Mutations Show Reduced Response Rates
source: pixabay.com

Patients with Unresectable Colorectal Liver Metastases and KRAS Mutations Show Reduced Response Rates

  Researchers have been able to identify similarities in outcomes between colorectal liver metastases that cannot be completely removed by surgery (unresectable) and patients with the KRAS mutation. Surgical resection…

Continue Reading Patients with Unresectable Colorectal Liver Metastases and KRAS Mutations Show Reduced Response Rates